These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 33774194)

  • 1. Emerging pathogenic role of peripheral blood factors following BBB disruption in neurodegenerative disease.
    Jeon MT; Kim KS; Kim ES; Lee S; Kim J; Hoe HS; Kim DG
    Ageing Res Rev; 2021 Jul; 68():101333. PubMed ID: 33774194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifaceted Role of Matrix Metalloproteinases in Neurodegenerative Diseases: Pathophysiological and Therapeutic Perspectives.
    Behl T; Kaur G; Sehgal A; Bhardwaj S; Singh S; Buhas C; Judea-Pusta C; Uivarosan D; Munteanu MA; Bungau S
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The blood-brain barrier, a key bridge to treat neurodegenerative diseases.
    Hang Z; Zhou L; Xing C; Wen Y; Du H
    Ageing Res Rev; 2023 Nov; 91():102070. PubMed ID: 37704051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mast cells in neuroinflammation and brain disorders.
    Hendriksen E; van Bergeijk D; Oosting RS; Redegeld FA
    Neurosci Biobehav Rev; 2017 Aug; 79():119-133. PubMed ID: 28499503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo.
    Tietz SM; Engelhardt B
    J Vis Exp; 2019 Mar; (145):. PubMed ID: 30985749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurodegenerative disorders: Mechanisms of degeneration and therapeutic approaches with their clinical relevance.
    Gadhave DG; Sugandhi VV; Jha SK; Nangare SN; Gupta G; Singh SK; Dua K; Cho H; Hansbro PM; Paudel KR
    Ageing Res Rev; 2024 Aug; 99():102357. PubMed ID: 38830548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCR7: A key neuroprotective molecule against alarmin HMGB1 mediated CNS pathophysiology and subsequent memory impairment.
    Das S; Mishra KP; Chanda S; Ganju L; Singh SB
    Brain Behav Immun; 2019 Nov; 82():319-337. PubMed ID: 31505255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral Infection of the Central Nervous System and Neuroinflammation Precede Blood-Brain Barrier Disruption during Japanese Encephalitis Virus Infection.
    Li F; Wang Y; Yu L; Cao S; Wang K; Yuan J; Wang C; Wang K; Cui M; Fu ZF
    J Virol; 2015 May; 89(10):5602-14. PubMed ID: 25762733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Mobility Group Box-1 and Blood-Brain Barrier Disruption.
    Nishibori M; Wang D; Ousaka D; Wake H
    Cells; 2020 Dec; 9(12):. PubMed ID: 33321691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging Roles of Microglia in Blood-Brain Barrier Integrity in Aging and Neurodegeneration.
    Zhang S; Meng R; Jiang M; Qing H; Ni J
    Curr Neuropharmacol; 2024; 22(7):1189-1204. PubMed ID: 36740799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-neuronal Cells in ALS: Role of Glial, Immune cells and Blood-CNS Barriers.
    Puentes F; Malaspina A; van Noort JM; Amor S
    Brain Pathol; 2016 Mar; 26(2):248-57. PubMed ID: 26780491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer's disease.
    Festoff BW; Sajja RK; van Dreden P; Cucullo L
    J Neuroinflammation; 2016 Aug; 13(1):194. PubMed ID: 27553758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A validated quantitative method for the assessment of neuroprotective barrier impairment in neurodegenerative disease models.
    Kumar V; Lee JD; Coulson EJ; Woodruff TM
    J Neurochem; 2021 Aug; 158(3):807-817. PubMed ID: 32628780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the blood brain barrier in neurodegenerative disorders and their treatment.
    Palmer AM
    J Alzheimers Dis; 2011; 24(4):643-56. PubMed ID: 21460432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tau Protein and Its Role in Blood-Brain Barrier Dysfunction.
    Michalicova A; Majerova P; Kovac A
    Front Mol Neurosci; 2020; 13():570045. PubMed ID: 33100967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulatory effects of perforin gene dosage on pathogen-associated blood-brain barrier (BBB) disruption.
    Willenbring RC; Jin F; Hinton DJ; Hansen M; Choi DS; Pavelko KD; Johnson AJ
    J Neuroinflammation; 2016 Aug; 13(1):222. PubMed ID: 27576583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement in the brain.
    Veerhuis R; Nielsen HM; Tenner AJ
    Mol Immunol; 2011 Aug; 48(14):1592-603. PubMed ID: 21546088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders.
    Sweeney MD; Sagare AP; Zlokovic BV
    Nat Rev Neurol; 2018 Mar; 14(3):133-150. PubMed ID: 29377008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glial expression of disease-associated poly-glutamine proteins impairs the blood-brain barrier in Drosophila.
    Yeh PA; Liu YH; Chu WC; Liu JY; Sun YH
    Hum Mol Genet; 2018 Jul; 27(14):2546-2562. PubMed ID: 29726932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut reactions: How the blood-brain barrier connects the microbiome and the brain.
    Logsdon AF; Erickson MA; Rhea EM; Salameh TS; Banks WA
    Exp Biol Med (Maywood); 2018 Jan; 243(2):159-165. PubMed ID: 29169241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.